@article{d6c2e243a94247f9ba748b1b6797282a,
title = "Surgical complications in the tube versus trabeculectomy study during the first year of follow-up",
abstract = "PURPOSE: To describe the intraoperative and postoperative complications encountered during the first year of follow-up in the Tube Versus Trabeculectomy (TVT) Study. • DESIGN: Multicenter randomized clinical trial. • METHODS: SETTING: Seventeen clinical centers. STUDY POPULATION: Two hundred twelve patients aged 18 to 85 years who had undergone previous trabeculectomy and/or cataract extraction with intraocular lens implantation and uncontrolled glaucoma with intraocular pressure ≥18 mm Hg and ≤40 mm Hg on maximum tolerated medical therapy. INTERVENTIONS: A 350-mm2 Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC). MAIN OUTCOME MEASURES: Surgical complications, reoperation for complications, visual acuity, and cataract progression. • RESULTS: Intraoperative complications occurred in seven patients (7%) in the tube group and 10 patients (10%) in the trabeculectomy group (P =.59). Postoperative complications developed in 36 patients (34%) in the tube group and 60 patients (57%) in the trabeculectomy group during the first year of follow-up (P=.001). Surgical complications were associated with reoperation and/or loss of ≥2 lines of Snellen visual acuity in 18 patients (17%) in the tube group and 28 patients (27%) in the trabeculectomy group (P=12). • CONCLUSIONS: There were a large number of surgical complications during the first year of follow-up in the study, but most were self-limited. The incidence of postoperative complications was higher after trabeculectomy with MMC than nonvalved tube shunt surgery. Serious complications resulting in reoperation and/or vision loss occurred with similar frequency with both surgical procedures.",
author = "{TUBE VERSUS TRABECULECTOMY STUDY GROUP} and Gedde, {Steven J.} and Herndon, {Leon W.} and Brandt, {James D.} and Budenz, {Donald L.} and Feuer, {William J.} and Schiffman, {Joyce C.} and Douglas Anderson and {Del Calvo}, Madeline and Francisco Fantes and David Greenfield and Elizabeth Hodapp and Richard Lee and Alexia Marcellino and Paul Palmberg and Richard Parrish and Pratap Challa and Cecile Santiago-Turla and Dunn, {Darrell Wu} and Geoffrey Emerick and Dale Heuer and Alexander Kent and Carol Bradham and Lisa Langdale and Keith Barton and Francesca Amalfitano and Poornima Rai and Paul Sidoti and Amy Gedal and James Luayon and Roma Ovase and Katy Tai and Quang Nguyen and Neva Miller and Steven Shields and Kevin Anderson and Frank Moya and Michele Lim and Marilyn Sponzo and Mark Sherwood and Revonda Burke and Gregory Skuta and Jason Jobson and Lisa Ogilbee and Adam Reynolds and Rohit Varma and Brian Francis and Frances Walonker and Robert Feldman and Laura Baker and Nicholas Bell",
note = "Funding Information: This study was supported by research grants from Pfizer, Inc, New York, New York; Advanced Medical Optics, Irvine, California; the National Eye Institute (Grant EY014801), National Institutes of Health, Bethesda, Maryland, and Research to Prevent Blindness, Inc, New York, New York. The authors indicate financial conflict of interest (see complete list of investigators at AJO.com). All the authors and list of investigators were involved in collection, management, analysis, and interpretation of data, and preparation of the data and revision including references; involved in collection of data; and involved in management, statistical analysis and interpretation of the data, and preparation of the manuscript. Funding Information: Keith Barton, M.D.: Pfizer, honoraria. James Brandt, M.D.: Pfizer, consultant, speakers bureau, honoraria; Advanced Medical Optics, consultant. Donald Budenz, M.D., M.P.H.: Pfizer, honoraria, speakers bureau. Philip Chen, M.D.: Pfizer, honoraria. Geoffrey Emerick, M.D.: Pfizer, honoraria, speakers bureau. Francisco Fantes, M.D.: Pfizer, speakers bureau. Robert Feldman, M.D.: Pfizer, consultant, grant support, honoraria, speakers bureau. Brian Francis, M.D.: Pfizer, speakers bureau. Steven Gedde, M.D.: Pfizer, honoraria, speakers bureau; Advanced Medical Optics, honoraria. David Greenfield, M.D.: Pfizer, consultant, honoraria, speakers bureau. Leon Herndon, M.D.: Pfizer, honoraria, speakers bureau. Dale Heuer, M.D.: Pfizer, honoraria, speakers bureau. Paul Kaufman, M.D.: Pfizer, consultant, grant support, honoraria, speakers bureau, travel expenses; Advanced Medical Optics, consultant, grant support. Richard Lee, M.D., Ph.D.: Pfizer, speakers bureau. Frank Moya, M.D.: Pfizer, speakers bureau. Quang Nguyen, M.D.: Pfizer, consultant, honoraria, speakers bureau. Paul Palmberg, M.D., Ph.D.: Pfizer, consultant, speakers bureau, honoraria. Richard Parrish II, M.D.: Pfizer, consultant, honoraria. Bruce Prum, M.D.: Pfizer, grant support, speakers bureau. Adam Reynolds, M.D.: Pfizer, honoraria. Steven Shields, M.D.: Pfizer, consultant. Kuldev Singh, M.D., M.P.H.: Pfizer, consultant. Gregory Skuta, M.D.: Pfizer, consultant, honoraria, speakers bureau. George Spaeth, M.D.: Pfizer, grant support, honoraria. Rohit Varma, M.D., M.P.H.: Pfizer, consultant, grant support, honoraria, speakers bureau. Martha Wright, M.D.: Pfizer, speakers bureau. Darrell WuDunn, M.D., Ph.D.: Pfizer, honoraria, speakers bureau. Publisher Copyright: {\textcopyright} 2007 by Elsevier Inc. All rights reserved.",
year = "2007",
month = jan,
doi = "10.1016/j.ajo.2006.07.022",
language = "English",
volume = "143",
pages = "31.e2",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "1",
}